Liver Regeneration
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Liver Regeneration trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Liver Regeneration trials you may qualify forHepatobiliary malignancies-principally hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA)-are highly aggressive and often diagnosed at advanced stages.…
Posthepatectomy liver failure (PHLF) remains a significant life-threatening problem after major hepatectomies. Pentoxifylline is shown to have potent vasodilati…
the investigators will pursue two specific aims: (1) to monitor the extent of heme oxygenase induction (by measuring endogenous CO production) in relationship t…
The goal of the DRAGON PLC clinical trial is to determine whether portal vein embolization (PVE) combined with hepatic vein embolization (HVE) improves resectab…
The primary objective of this interventional study is determine if the future liver remnant can be optimized by improving liver function pre-operatively in pati…
Rationale: Living donor liver transplantation (LDLT) offers a promising solution to the organ shortage. During living liver donation, a substantial portion of t…
Hepatorenal Syndrome (HRS) is a serious complication that can occur in patients with liver cirrhosis, characterised by kidney dysfunction, or acute kidney failu…